Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Suely Maymone de Melo"'
Autor:
Suely Maymone de Melo, Gustavo Nader Marta, Carolina de Oliveira Cruz Latorraca, Camila Bertini Martins, Orestis Efthimiou, Rachel Riera
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Objective To evaluate different hypofractionated radiotherapy (HRT) regimens for newly diagnosed elderly glioblastoma (GBM) patients. Methods We performed a systematic review with network meta-analysis (NMA), including searches on CENTRAL, Medline, E
Externí odkaz:
https://doaj.org/article/84a5af65d0c64b21b63dc5e640ec16fa
Autor:
Suely Maymone de Melo, Simone Bittencourt, Enéas Galdini Ferrazoli, Clivandir Severino da Silva, Flavia Franco da Cunha, Flavia Helena da Silva, Roberta Sessa Stilhano, Priscila Martins Andrade Denapoli, Bianca Ferrarini Zanetti, Priscila Keiko Matsumoto Martin, Leonardo Martins Silva, Adara Aurea dos Santos, Leandra Santos Baptista, Beatriz Monteiro Longo, Sang Won Han
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128922 (2015)
Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted t
Externí odkaz:
https://doaj.org/article/54b309cd0471482b88deb1e3bd04804a
Autor:
Gustavo Nader Marta, Carol Cruz, Michael Yan, Rachel Riera, Fabio Y. Moraes, Suely Maymone de Melo
Publikováno v:
Annals of Palliative Medicine. 9:3553-3561
Glioblastoma (GBM) is one of the most malignant primary intracranial neoplasms. This review aims to summarize the treatment of elderly patients with newly diagnosed GBM, with a focus on the radiation therapy (RT) approach. The available literature wa
Autor:
Carolina de Oliveira Cruz Latorraca, Rachel Riera, Gustavo Nader Marta, Orestis Efthimiou, Camila Bertini Martins, Suely Maymone de Melo
Publikováno v:
Melo, Suely Maymone de; Marta, Gustavo Nader; Latorraca, Carolina de Oliveira Cruz; Martins, Camila Bertini; Efthimiou, Orestis; Riera, Rachel (2021). Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis. PLoS ONE, 16(11), e0257384. Public Library of Science 10.1371/journal.pone.0257384
PLoS ONE, Vol 16, Iss 11, p e0257384 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0257384 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
Objective To evaluate different hypofractionated radiotherapy (HRT) regimens for newly diagnosed elderly glioblastoma (GBM) patients. Methods We performed a systematic review with network meta-analysis (NMA), including searches on CENTRAL, Medline, E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d075b01df8a0b8c6fda1adac2c0021b
https://boris.unibe.ch/160852/1/Melo_PLoSOne_2021.pdf
https://boris.unibe.ch/160852/1/Melo_PLoSOne_2021.pdf
Publikováno v:
JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA. 20:143-158
Radiosurgery (SRS) or Stereotactic Radiotherapy (SRT) is a standard procedure as second-line treatment in patients with pituitary adenoma, when cure with the initial surgical and/or hormonal treatment is not possible. When compared to conventional Ra
α-l -iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice
Autor:
Yara M. Michelacci, Suely Maymone de Melo, Vivian Yochiko Samoto, Flávia Helena da Silva, Adriana Taveira da Cruz, Vania D'Almeida, Vanessa Gonçalves Pereira, Sang Won Han, Roberta Sessa Stilhano, Miriam Galvonas Jasiulionis, Priscila Keiko Matsumoto Martin, Giovani B. Peres
Publikováno v:
The Journal of Gene Medicine. 17:1-13
Background Mucopolysaccharidose type I (MPSI) is a lysosomal monogenic disease caused by mutations in the gene for α- l-iduronidase (IDUA). MPSI patients need a constant supply of IDUA to alleviate progression of the disease. IDUA gene transfer usin
Autor:
Mauricio En Elias Nunes da Silva, Fabio Y. Moraes, Gustavo Jm Porfírio, Suely Maymone de Melo, Rachel Riera, Kelly De Cicco, Maria Regina Torloni
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with glioma.
Autor:
Beatriz M. Longo, Clivandir Severino da Silva, Simone Bittencourt, Roberta Sessa Stilhano, Sang Won Han, Priscila Keiko Matsumoto Martin, Bianca Ferrarini Zanetti, Priscila Martins Andrade Denapoli, Flávia Helena da Silva, Adara Aurea dos Santos, Leandra Santos Baptista, Suely Maymone de Melo, Enéas Galdini Ferrazoli, Flavia Franco da Cunha, Leonardo Martins Silva
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128922 (2015)
PLoS ONE
PLoS ONE
Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted t
Autor:
Roberta Sessa, Stilhano, Priscila Keiko Matsumoto, Martin, Suely Maymone, de Melo, Vivian Yochiko, Samoto, Giovani Bravin, Peres, Yara Maria Correa, da Silva Michelacci, Flavia Helena, da Silva, Vanessa Gonçalves, Pereira, Vania, D'Almeida, Adriana Taveira, da Cruz, Miriam Galvonas, Jasiulionis, Sang Won, Han
Publikováno v:
The journal of gene medicine. 17(1-2)
Mucopolysaccharidose type I (MPSI) is a lysosomal monogenic disease caused by mutations in the gene for α- L-iduronidase (IDUA). MPSI patients need a constant supply of IDUA to alleviate progression of the disease. IDUA gene transfer using integrati
Autor:
Adara Aurea dos Santos, Roberta Sessa Stilhano, Leandra Santos Baptista, Priscila Martins Andrade Denapoli, Leonardo Martins Silva, Enéas Galdini Ferrazoli, Beatriz M. Longo, Simone Bittencourt, Suely Maymone de Melo, Sang Won Han, Pricila K. Martins, Clivandir Severino da Silva, Bianca Ferrarini Zanetti, Flavia Franco da Cunha
Publikováno v:
Molecular Therapy. 23:S253
Glioblastoma (GBM) is the most common and lethal primary intracranial tumor. Because GBM is highly invasive and diffusely infiltrates the brain, a complete resection of the tumor is unfeasible. The gene encoding thymidine kinase from herpes simplex v